LivaNova PLC (LIVN)

NASDAQ
Currency in USD
41.88
-1.30(-3.01%)
Closed·
After Hours
42.71+0.84(+2.01%)
·
LIVN Scorecard
Full Analysis
Net income is expected to grow this year
LIVN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
41.7342.98
52 wk Range
32.4861.94
Key Statistics
Edit
Prev. Close
43.18
Open
42.77
Day's Range
41.73-42.98
52 wk Range
32.48-61.94
Volume
602.74K
Average Volume (3m)
889.18K
1-Year Change
-29.47%
Book Value / Share
19.03
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LIVN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
61.36
Upside
+46.52%
Members' Sentiments
Bearish
Bullish
ProTips
7 analysts have revised their earnings downwards for the upcoming period
Show more

LivaNova PLC Company Profile

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related accessories. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; and devices that deliver neuromodulation therapy for treating difficult-to-treat depression and drug-resistant epilepsy. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its medical devices through a combination of direct sales representatives, agents, and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

LivaNova PLC SWOT Analysis


Sleep Apnea Breakthrough
LivaNova's OSPREY trial reveals promising results for its Obstructive Sleep Apnea platform, potentially tapping into a large market by 2026
Depression Treatment Dilemma
Mixed results from the RECOVER trial for VNS Therapy in depression treatment prompt strategic reassessment, with future plans eagerly anticipated
Financial Health Check
LivaNova maintains a strong financial position with revenue growth of 11% over 12 months and an "GREAT" financial health score from InvestingPro
Market Valuation Insights
With a market cap of $2.88 billion and an analyst price target of $61.00, LivaNova's stock shows potential upside amid evolving growth strategies
Read full SWOT analysis

LivaNova PLC Earnings Call Summary for Q3/2024

  • LivaNova reports 11% Q3 revenue growth, raises 2024 outlook to 8.5%-9.5% revenue growth and $3.30-$3.40 adjusted EPS
  • Cardiopulmonary revenue up 15%, epilepsy revenue up 9%; Essenz heart-lung machine contributes 400 basis points to growth
  • Adjusted operating income for ACS segment rises to $64M from $45M; adjusted free cash flow increases to $47M from $26M
  • Company expects 10% manufacturing output increase from late 2023 to late 2024, aims for 100% Essenz system penetration in 3 years
  • LivaNova anticipates margin growth to outpace revenue in 2025, with EPS growth projected above 20% for 2024
Last Updated: 31/10/2024, 10:32 pm
Read Full Transcript

Compare LIVN to Peers and Sector

Metrics to compare
LIVN
Peers
Sector
Relationship
P/E Ratio
−10.3x21.5x−0.4x
PEG Ratio
0.020.120.00
Price/Book
2.2x2.9x2.6x
Price / LTM Sales
1.8x4.8x2.9x
Upside (Analyst Target)
43.3%56.3%51.7%
Fair Value Upside
Unlock5.5%9.5%Unlock

Analyst Ratings

9 Buy
2 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 61.36
(+46.52% Upside)

Earnings

Latest Release
May 07, 2025
EPS / Forecast
0.88 / 0.76
Revenue / Forecast
316.90M / 302.38M
EPS Revisions
Last 90 days

People Also Watch

31.41
OPCH
-1.94%
73.86
LNTH
-1.19%
27.16
VCYT
-0.88%
95.10
CALM
+0.09%
174.70
POWL
+0.83%

FAQ

What Is the LivaNova PLC (LIVN) Stock Price Today?

The LivaNova PLC stock price today is 41.88

What Stock Exchange Does LivaNova PLC Trade On?

LivaNova PLC is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for LivaNova PLC?

The stock symbol for LivaNova PLC is "LIVN."

What Is the LivaNova PLC Market Cap?

As of today, LivaNova PLC market cap is 2.28B.

What Is LivaNova PLC's Earnings Per Share (TTM)?

The LivaNova PLC EPS (TTM) is -4.09.

When Is the Next LivaNova PLC Earnings Date?

LivaNova PLC will release its next earnings report on 29 July 2025.

From a Technical Analysis Perspective, Is LIVN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has LivaNova PLC Stock Split?

LivaNova PLC has split 0 times.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.